13F Insight
DOSSIER · 13F Holders · Q2 2026
ENGN

Engene Therapeutics Inc

4 institutions still hold Engene Therapeutics Inc as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 29286X101·4 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$280K
visible holders
Holders
4
filers reporting
Concentration
93.12%
Marquette Asset Management, LLC #1
top holder share
AI Holders Summary · Q2 2026

4 institutions reported ENGN in Q2 2026. Marquette Asset Management, LLC leads at 93.1% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Marquette Asset Management, LLC
CIK 0001395067
$260K151K0.03%Q2 202602
PFS Partners, LLC
CIK 0002002654
$19K11K0.01%Q2 202603
Farther Finance Advisors, LLC
CIK 0001992825
$1731000.00%Q2 202604
SBI Securities Co., Ltd.
CIK 0001851815
$48280.00%Q2 2026
Insiders at Engene Therapeutics Inc
Grossman William →Glickman Richard M →Brunk Gerald A →Astley-Sparke Philip →Zoth Lota S. →Joustra Wouter →Heffernan Michael Thomas →Hastings Paul J →